
1. viral immunol. 2017 mar;30(2):98-105. doi: 10.1089/vim.2016.0103. epub 2017 feb
2.

role tlr9 oncogenic virus-produced cancer.

martínez-campos c(1), burguete-garcía ai(1), madrid-marina v(1).

author information: 
(1)dirección de infecciones crónicas cáncer, centro de investigación sobre
enfermedades infecciosas, instituto nacional de salud pública, cuernavaca ,
morelos, mexico .

nucleic acid recognition toll-like receptor 9 (tlr9) initiates signaling
pathways regulate production proinflammatory cytokines type i
interferons, well many molecules required initialize immune
response. use synthetic oligodeoxynucleotides (odns) crucial to
emulate recognition dna sequences tlr9. furthermore, odn administration
to mice shown confer protection wide range viral, bacterial, 
and parasitic pathogens. contrast, oncogenic dna viruses like hepatitis b
virus, epstein-barr virus, human papilloma virus inhibit tlr9 expression,
thus contributing establishment chronic viral infections. this
review, focus tlr9 signals initiated odn recognition, the
inhibition tlr9 expression mediated dna oncogenic viruses, tlr9
expression relevant event progression cancer, considering other
functions receptor, aside viral recognition.

doi: 10.1089/vim.2016.0103 
pmid: 28151089  [indexed medline]

